TAMOXIFEN Side Effects

6769660-4 | Cerebral Artery Occlusion, Cerebral Infarction, Cerebrovascular Accident, Thrombosis
on Jun 01, 2010 Female patient from UNITED STATES , 51 years of age, was diagnosed with prophylaxis, breast cancer (What is breast cancer?), headache (What is headache?), dyspepsia, insomnia and was treated with Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral artery occlusion, cerebral infarction, cerebrovascular accident, thrombosis. Tamoxifen dosage: . During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), PEPCID (View Pepcid Review and Pepcid Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), VITAMIN D (1000 Unit Daily) (View Vitamin D Review and Vitamin D Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), BENADRYL (View Benadryl Review and Benadryl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6296067-9 | Bronchopulmonary Dysplasia, Renal Failure Chronic, Respiratory Arrest
Patient was taking Tamoxifen (View Usage). Patient had the following side effects: bronchopulmonary dysplasia, renal failure chronic, respiratory arrest on Jul 31, 2009 from NEW ZEALAND Additional patient health information: Male patient , weighting 3.53 lb, . Tamoxifen dosage: Taken Intermittenly. During the same period patient was treated with HERCEPTIN (View Herceptin Review and Herceptin Label ), METHADONE (View Methadone Review and Methadone Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), STEROIDS (View Steroids Review and Steroids Label ).

5999516-6 | Leiomyoma
Adverse event was reported on Dec 10, 2008 by a Female patient taking Tamoxifen (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 34 years of age, After Tamoxifen was administered, patient had the following side effects: leiomyoma.

5983764-5 | Arthropathy, Blood Heavy Metal Increased, Burning Sensation, Dysuria, Gastrointestinal Haemorrhage, Oestradiol Increased
on Feb 13, 2006 Female patient from UNITED STATES , 49 years of age, weighting 112.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: arthropathy, blood heavy metal increased, burning sensation, dysuria, gastrointestinal haemorrhage, oestradiol increased. Tamoxifen dosage: .


5965093-9 | Confusional State, Diabetes Mellitus, Hyperhidrosis
on Nov 19, 2008 Female patient from UNITED STATES , weighting 164.9 lb, was diagnosed with breast cancer female and was treated with Tamoxifen (View Usage). Patient had the following side effects: confusional state, diabetes mellitus, hyperhidrosis. Tamoxifen dosage: .

5962220-4 | Depressed Mood
Patient was taking Tamoxifen (View Usage). After Tamoxifen was administered, patient had the following side effects: depressed mood on Nov 17, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 60 years of age, weighting 251.3 lb, was diagnosed with breast cancer recurrent, depression (What is depression?) and. Tamoxifen dosage: . During the same period patient was treated with VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ).

5945073-X | Electrocardiogram Qt Prolonged
Adverse event was reported on Nov 04, 2008 by a Female patient taking Tamoxifen (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?), hypertension and. Location: UNITED KINGDOM , 45 years of age, weighting 203.0 lb, Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged. During the same period patient was treated with BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), EXEMESTANE (View Exemestane Review and Exemestane Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), TRIPTAFEN (View Triptafen Review and Triptafen Label ).

5943892-7 | Diabetes Mellitus, Weight Increased
on Oct 31, 2008 Female patient from CANADA , 63 years of age, was diagnosed with breast cancer (What is breast cancer?), diabetes mellitus, hypertension and was treated with Tamoxifen (View Usage). Patient had the following side effects: diabetes mellitus, weight increased. Tamoxifen dosage: . During the same period patient was treated with INSULIN R AND N (View Insulin R And N Review and Insulin R And N Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ATACAND (View Atacand Review and Atacand Label ), NORVASC (View Norvasc Review and Norvasc Label ), CLODRONATE (1600 Mg) (View Clodronate Review and Clodronate Label ).

5937907-X | Oophorectomy Bilateral
on Oct 29, 2008 Female patient from UNITED STATES , 40 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tamoxifen (View Usage). After Tamoxifen was administered, patient had the following side effects: oophorectomy bilateral. Tamoxifen dosage: .

5775060-6 | Contusion, Dementia Alzheimer's Type, Dizziness, Fall, Fatigue, Gingival Bleeding, Headache, Memory Impairment, Mouth Haemorrhage
Patient was taking Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: contusion, dementia alzheimer's type, dizziness (What is dizziness?), fall (What is fall?), fatigue, gingival bleeding, headache (What is headache?), memory impairment, mouth haemorrhage on Jun 16, 2008 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 170.0 lb, . Tamoxifen dosage: 1 1x Day Po. During the same period patient was treated with RAMOXIFEN (View Ramoxifen Review and Ramoxifen Label ), EVISTA (View Evista Review and Evista Label ).

5715950-3 | Adenocarcinoma Of The Cervix, Endometrial Cancer Stage I, Gastric Cancer
Adverse event was reported on Apr 16, 2008 by a Female patient taking Tamoxifen (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?), gastric cancer and. Location: TURKEY , 75 years of age, Patient had the following side effects: adenocarcinoma of the cervix, endometrial cancer stage i, gastric cancer. During the same period patient was treated with MITOMYCIN (View Mitomycin Review and Mitomycin Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

5711226-9 | Breast Cancer In Situ, Contusion, Fall, Weight Decreased
on Apr 15, 2008 Female patient from BRAZIL , 63 years of age, weighting 147.7 lb, was diagnosed with breast cancer (What is breast cancer?), osteoporosis prophylaxis, hypothyroidism and was treated with Tamoxifen (View Usage). After Tamoxifen was administered, patient had the following side effects: breast cancer in situ, contusion, fall (What is fall?), weight decreased. Tamoxifen dosage: . During the same period patient was treated with ARIMIDEX (View Arimidex Review and Arimidex Label ), PROTOS (View Protos Review and Protos Label ), PURAN T4 (View Puran T4 Review and Puran T4 Label ).

5669746-1 | Alopecia, Cervix Enlargement, Dyspnoea, Endometrial Disorder, Fall, Hair Texture Abnormal, Impaired Healing, Libido Decreased, Onychoclasis
on Mar 11, 2008 Female patient from BRAZIL , 49 years of age, weighting 116.8 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, cervix enlargement, dyspnoea, endometrial disorder, fall (What is fall?), hair texture abnormal, impaired healing, libido decreased, onychoclasis. Tamoxifen dosage: . During the same period patient was treated with ARIMIDEX (View Arimidex Review and Arimidex Label ).

5664259-5 | Osteonecrosis, Weight Decreased
Patient was taking Tamoxifen (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?), weight decreased on Mar 10, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 51 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Tamoxifen dosage: . During the same period patient was treated with ANASTROZOLE (View Anastrozole Review and Anastrozole Label ), EXEMESTANE (View Exemestane Review and Exemestane Label ), CLODRONATE (View Clodronate Review and Clodronate Label ), PAMIDRONATE DISODIUM (Eleven Monthly Cycles) (View Pamidronate Disodium Review and Pamidronate Disodium Label ), ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ), IBANDRONIC ACID (View Ibandronic Acid Review and Ibandronic Acid Label ), CYCLOPHOSPHAMIDE (6 Cycles) (View Cyclophosphamide Review and Cyclophosphamide Label ), METHOTREXATE (6 Cycles) (View Methotrexate Review and Methotrexate Label ).

5663976-0 | Vomiting
Adverse event was reported on Mar 03, 2008 by a Female patient taking Tamoxifen (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 42 years of age, After Tamoxifen was administered, patient had the following side effects: vomiting. During the same period patient was treated with VARENICLINE TARTRATE (CHAMPIX) (View Varenicline Tartrate (champix) Review and Varenicline Tartrate (champix) Label ).

5662903-X | Ovarian Cyst
on Mar 05, 2008 Female patient from UNITED STATES , 65 years of age, was treated with Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian cyst (What is ovarian cyst?). Tamoxifen dosage: . During the same period patient was treated with ACTONEL (View Actonel Review and Actonel Label ), NEXIUM (View Nexium Review and Nexium Label ), OSCAL (View Oscal Review and Oscal Label ).

5661840-4 | Thrombosis
on Mar 05, 2008 Female patient from UNITED STATES , 42 years of age, was treated with Tamoxifen (View Usage). Patient had the following side effects: thrombosis. Tamoxifen dosage: .

5660886-X | Disease Progression, Recurrent Cancer, Surgery
Patient was taking Tamoxifen (View Usage). After Tamoxifen was administered, patient had the following side effects: disease progression, recurrent cancer, surgery (What is surgery?) on Mar 05, 2008 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 182.1 lb, was diagnosed with breast cancer (What is breast cancer?) and. Tamoxifen dosage: . During the same period patient was treated with ARIMIDEX (View Arimidex Review and Arimidex Label ), PRILOSEC (View Prilosec Review and Prilosec Label ).

5652947-6 | Vomiting
Adverse event was reported on Feb 29, 2008 by a Female patient taking Tamoxifen (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 42 years of age, Patient experienced the following unwanted or unexpected effects: vomiting. During the same period patient was treated with CHANTIX (View Chantix Review and Chantix Label ).

5643239-X | Vaginal Prolapse
on Feb 19, 2008 Female patient from UNITED KINGDOM , 83 years of age, weighting 143.3 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tamoxifen (View Usage). Patient had the following side effects: vaginal prolapse. Tamoxifen dosage: . Patient was hospitalized and became disabled.

5643208-X | Vaginal Prolapse
on Feb 19, 2008 Female patient from UNITED KINGDOM , 83 years of age, weighting 143.3 lb, was diagnosed with breast cancer (What is breast cancer?), hypersensitivity, skin infection, intermittent claudication, gastrooesophageal reflux disease and was treated with Tamoxifen (View Usage). After Tamoxifen was administered, patient had the following side effects: vaginal prolapse. Tamoxifen dosage: . During the same period patient was treated with CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), CLOTRIMAZOLE (1% Strength) (View Clotrimazole Review and Clotrimazole Label ), FUCIDINE CAP (View Fucidine Cap Review and Fucidine Cap Label ), PRAXILENE (View Praxilene Review and Praxilene Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized and became disabled.

5641654-1 | Cerebral Haemorrhage, Coronary Artery Embolism, Coronary Artery Occlusion, Myocardial Infarction
Patient was taking Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, coronary artery embolism, coronary artery occlusion, myocardial infarction on Feb 13, 2008 from BELGIUM Additional patient health information: Male patient , 64 years of age, was diagnosed with gynaecomastia and. Tamoxifen dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

5634884-6 | Breast Cancer, Breast Cancer Recurrent
Adverse event was reported on Feb 18, 2008 by a Female patient taking Tamoxifen (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 67 years of age, Patient had the following side effects: breast cancer (What is breast cancer?), breast cancer recurrent.

5634537-4 | Aggression, Crying, Dyspepsia, Hypertension, Irritability, Mood Swings, Nervousness
on Feb 14, 2008 Female patient from UNITED KINGDOM , 63 years of age, weighting 150.9 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tamoxifen (View Usage). After Tamoxifen was administered, patient had the following side effects: aggression, crying, dyspepsia, hypertension, irritability, mood swings, nervousness. Tamoxifen dosage: . During the same period patient was treated with EZETIMIBE (10 Mg, Qd) (View Ezetimibe Review and Ezetimibe Label ), LETROZOLE (2.5 Mg, Unk) (View Letrozole Review and Letrozole Label ).

5626504-1 | Anaemia, Chest Pain, Constipation, Depression, Disease Progression, Dyspnoea, Haemorrhage, Metastatic Neoplasm, Obstruction
on Feb 07, 2008 Female patient from BRAZIL , 82 years of age, was diagnosed with breast cancer female, hypertension and was treated with Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, chest pain (What is chest pain?), constipation (What is constipation?), depression (What is depression?), disease progression, dyspnoea, haemorrhage, metastatic neoplasm, obstruction. Tamoxifen dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), MONOCORDIL (View Monocordil Review and Monocordil Label ). Patient was hospitalized.

5621730-X | Colon Cancer
Patient was taking Tamoxifen (View Usage). Patient had the following side effects: colon cancer on Jan 30, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 70 years of age, was diagnosed with breast cancer stage ii and. Tamoxifen dosage: .

5619830-3 | Condition Aggravated, Dental Caries, Pain, Pulmonary Embolism, Tooth Loss, Tooth Repair
Adverse event was reported on Feb 01, 2008 by a Female patient taking Tamoxifen (View Usage) (Dosage: Unk Qd) was diagnosed with breast cancer metastatic, metastases to bone, prophylaxis and. Location: UNITED STATES , 75 years of age, After Tamoxifen was administered, patient had the following side effects: condition aggravated, dental caries, pain (What is pain?), pulmonary embolism (What is pulmonary embolism?), tooth loss, tooth repair. During the same period patient was treated with FASLODEX (250 Mg Monthly) (View Faslodex Review and Faslodex Label ), AROMASIN (View Aromasin Review and Aromasin Label ), ZOMETA (4 Mg Every 4 Weeks) (View Zometa Review and Zometa Label ), TAXOL (129 Mg, Weekly) (View Taxol Review and Taxol Label ), DECADRON (20mg Prior To Taxol) (View Decadron Review and Decadron Label ).

5615818-7 | Intentional Overdose, Suicide Attempt
on Jan 29, 2008 Female patient from BELGIUM , weighting 176.4 lb, was treated with Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: intentional overdose, suicide attempt. Tamoxifen dosage: .

5614068-8 | Osteonecrosis
on Jan 24, 2008 Female patient from UNITED KINGDOM , 51 years of age, was diagnosed with breast cancer (What is breast cancer?), metastasis and was treated with Tamoxifen (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Tamoxifen dosage: . During the same period patient was treated with ANASTROZOLE (View Anastrozole Review and Anastrozole Label ), EXEMESTANE (View Exemestane Review and Exemestane Label ), CLODRONATE DISODIUM (View Clodronate Disodium Review and Clodronate Disodium Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), IBANDRONIC ACID (View Ibandronic Acid Review and Ibandronic Acid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ).

5608078-4 | Gingival Recession, Tooth Loss
Patient was taking Tamoxifen (View Usage). After Tamoxifen was administered, patient had the following side effects: gingival recession, tooth loss on Jan 25, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 71 years of age, weighting 110.2 lb, . Tamoxifen dosage: .

5607280-5 | Gingival Recession, Tooth Loss
Adverse event was reported on Jan 25, 2008 by a Female patient taking Tamoxifen (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 71 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: gingival recession, tooth loss.

5605861-6 | Condition Aggravated, Dental Caries, Pain, Pulmonary Embolism, Tooth Loss, Tooth Repair
on Jan 21, 2008 Female patient from UNITED STATES , 75 years of age, was diagnosed with breast cancer metastatic, metastases to bone, prophylaxis and was treated with Tamoxifen (View Usage). Patient had the following side effects: condition aggravated, dental caries, pain (What is pain?), pulmonary embolism (What is pulmonary embolism?), tooth loss, tooth repair. Tamoxifen dosage: Unk Qd. During the same period patient was treated with FASLODEX (250 Mg Monthly) (View Faslodex Review and Faslodex Label ), AROMASIN (View Aromasin Review and Aromasin Label ), ZOMETA (4 Mg Every 4 Weeks) (View Zometa Review and Zometa Label ), TAXOL (129 Mg, Weekly) (View Taxol Review and Taxol Label ), DECADRON (20mg Prior To Taxol) (View Decadron Review and Decadron Label ).

5602591-1 | Metastatic Neoplasm, Rectal Polyp
on Jan 17, 2008 Female patient from BRAZIL , 82 years of age, was diagnosed with breast cancer female, hypertension, angina unstable and was treated with Tamoxifen (View Usage). After Tamoxifen was administered, patient had the following side effects: metastatic neoplasm, rectal polyp. Tamoxifen dosage: .

5599537-1 | Colon Cancer
Patient was taking Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: colon cancer on Jan 15, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 70 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Tamoxifen dosage: .

5586497-2 | Arthralgia, Carpal Tunnel Syndrome, Dry Skin, Eye Disorder, Hair Disorder, Nail Disorder, Nausea, Onychoclasis
Adverse event was reported on Nov 19, 2007 by a Female patient taking Tamoxifen (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?), type 2 diabetes mellitus, blood cholesterol increased and. Location: UNITED KINGDOM , 65 years of age, Patient had the following side effects: arthralgia, carpal tunnel syndrome (What is carpal tunnel syndrome?), dry skin, eye disorder, hair disorder, nail disorder, nausea (What is nausea?), onychoclasis. During the same period patient was treated with ARIMIDEX (View Arimidex Review and Arimidex Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ).

5453758-7 | Arthralgia, Dry Skin, Eye Disorder, Hair Disorder, Nail Disorder, Nausea, Onychoclasis, Pain Of Skin
on Sep 07, 2007 Female patient from UNITED KINGDOM , 65 years of age, was diagnosed with breast cancer (What is breast cancer?), type 2 diabetes mellitus, blood cholesterol increased and was treated with Tamoxifen (View Usage). After Tamoxifen was administered, patient had the following side effects: arthralgia, dry skin, eye disorder, hair disorder, nail disorder, nausea (What is nausea?), onychoclasis, pain of skin. Tamoxifen dosage: . During the same period patient was treated with ARIMIDEX (View Arimidex Review and Arimidex Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ).

5267525-0 | Endometrial Hypertrophy
on Jul 29, 2003 Female patient from UNITED STATES , 61 years of age, weighting 150.0 lb, was treated with Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: endometrial hypertrophy. Tamoxifen dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

5267514-6 | Uterine Polyp
Patient was taking Tamoxifen (View Usage). Patient had the following side effects: uterine polyp on Nov 20, 2003 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 113.0 lb, was diagnosed with breast cancer (What is breast cancer?) and. Tamoxifen dosage: 20 Mg Qd Po. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

5267513-4 | Endometrial Cancer
Adverse event was reported on Nov 12, 2003 by a Female patient taking Tamoxifen (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 142.0 lb, After Tamoxifen was administered, patient had the following side effects: endometrial cancer.

5267511-0 | Breast Cancer Recurrent
on Nov 05, 2003 Female patient from UNITED STATES , 56 years of age, weighting 134.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer recurrent. Tamoxifen dosage: 1 Mg Po. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), CALCIUM (View Calcium Review and Calcium Label ).

5267510-9 | Disease Progression
on Oct 29, 2003 Female patient from UNITED STATES , 65 years of age, weighting 145.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tamoxifen (View Usage). Patient had the following side effects: disease progression. Tamoxifen dosage: . During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ).

5267509-2 | Uterine Cancer
Patient was taking Tamoxifen (View Usage). After Tamoxifen was administered, patient had the following side effects: uterine cancer (What is uterine cancer?) on Nov 05, 2003 from UNITED STATES Additional patient health information: Female patient , 78 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Tamoxifen dosage: 20 Mg Qd Po. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ).

5267505-5 | Breast Cancer Recurrent, Feeling Abnormal, Feeling Hot, Hypotrichosis, Trichorrhexis, Vaginal Disorder, Weight Increased
Adverse event was reported on Mar 25, 2004 by a Female patient taking Tamoxifen (View Usage) (Dosage: 20 Mg Po) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 76 years of age, weighting 178.0 lb, Patient experienced the following unwanted or unexpected effects: breast cancer recurrent, feeling abnormal, feeling hot, hypotrichosis, trichorrhexis, vaginal disorder, weight increased.

5267503-1 | Disease Recurrence
on Mar 05, 2004 Female patient from UNITED STATES , 59 years of age, weighting 110.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tamoxifen (View Usage). Patient had the following side effects: disease recurrence. Tamoxifen dosage: . During the same period patient was treated with ACTONEL (View Actonel Review and Actonel Label ), FOSAMAX (View Fosamax Review and Fosamax Label ).

5267502-X | Endometrial Cancer
on Feb 27, 2004 Female patient from UNITED STATES , 58 years of age, weighting 200.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Tamoxifen (View Usage). After Tamoxifen was administered, patient had the following side effects: endometrial cancer. Tamoxifen dosage: . During the same period patient was treated with NOLVADEX (10 Mg Po) (View Nolvadex Review and Nolvadex Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), IMURAN (View Imuran Review and Imuran Label ).

5265624-0 | Vaginal Discharge, Vaginal Haemorrhage
Patient was taking Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: vaginal discharge, vaginal haemorrhage on Jul 16, 2002 from UNITED STATES Additional patient health information: Female patient , 67 years of age, . Tamoxifen dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ).

5265621-5 | Grand Mal Convulsion
Adverse event was reported on Jul 03, 2002 by a Female patient taking Tamoxifen (View Usage) (Dosage: 20 Mg Po) . Location: UNITED STATES , 37 years of age, Patient had the following side effects: grand mal convulsion. Patient was hospitalized.

5059442-6 | Splenomegaly
on Jul 19, 2006 Female patient from UNITED STATES , 45 years of age, was treated with Tamoxifen (View Usage). After Tamoxifen was administered, patient had the following side effects: splenomegaly. Tamoxifen dosage: .

5045772-0 | Anaesthesia, Bone Trimming, Dental Treatment, Gingival Recession, Gingivitis, Inflammation, Osteomyelitis, Osteonecrosis, Plastic Surgery
on Mar 31, 2005 Female patient from GERMANY , 61 years of age, was diagnosed with metastases to bone, breast cancer metastatic, breast cancer female and was treated with Tamoxifen (View Usage). Patient experienced the following unwanted or unexpected effects: anaesthesia, bone trimming, dental treatment, gingival recession, gingivitis, inflammation, osteomyelitis, osteonecrosis (What is osteonecrosis?), plastic surgery. Tamoxifen dosage: 20 Mg, Qd. During the same period patient was treated with LETROZOLE (View Letrozole Review and Letrozole Label ), ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ), AREDIA (90 Mg, Qmo) (View Aredia Review and Aredia Label ), BONDRONAT (6 Mg, Tiw) (View Bondronat Review and Bondronat Label ). Patient was hospitalized.

5034844-2 | Anaesthesia, Bone Trimming, Dental Treatment, Hypermetabolism, Osteomyelitis, Osteomyelitis Acute, Osteonecrosis, Periodontitis, Primary Sequestrum
Patient was taking Tamoxifen (View Usage). Patient had the following side effects: anaesthesia, bone trimming, dental treatment, hypermetabolism, osteomyelitis, osteomyelitis acute, osteonecrosis (What is osteonecrosis?), periodontitis, primary sequestrum on Sep 01, 2005 from GERMANY Additional patient health information: Female patient , 72 years of age, weighting 154.3 lb, was diagnosed with metastases to bone and. Tamoxifen dosage: 30 Mg, Unk. During the same period patient was treated with ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ), LETROZOLE (2.5 Mg, Qd) (View Letrozole Review and Letrozole Label ), AREDIA (90 Mg, Qmo) (View Aredia Review and Aredia Label ). Patient was hospitalized.